Showing results (21-30 of 238) with videos related to
Sort By:
Pageof 24
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Lymphokine mRNA profile and functional analysis of a human CD4+ clone with unique antitumor specificity isolated from renal cell carcinoma ascitic fluidA Belldegrun, A Kasid, M Uppenkamp, et al.Cancer Surveys|January 1, 1995
Gene therapy: principles and potentialS S Taneja, S Pang, P Cohan, et al.The Urologic Clinics of North America|November 1, 1994
Management of disseminated kidney cancerS S Taneja, W Pierce, R Figlin, et al.The Journal of Urology|June 24, 1999
Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapyJ Naitoh, A Kaplan, F Dorey, et al.Reviews in Urology|September 21, 2006
Nephron-sparing surgery for renal cell carcinomaK H Tsui, A van Ophoven, O Shvarts, et al.Seminars in Oncology|April 18, 2000
Adoptive cellular therapyD M Hoffman, B J Gitlitz, A Belldegrun, et al.CA: a Cancer Journal for Clinicians|September 1, 1996
Current management of renal cell carcinomaM H Sokoloff, J B deKernion, R A Figlin, et al.Cancer Surveys|January 1, 1995
Surgery from a US perspectiveJ B Dekernion, J R Franklin, A Belldegrun, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinomaR A Figlin, A Belldegrun, N Moldawer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging systemA Belldegrun, K H Tsui, J B deKernion, et al.Pageof 24